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Background
•
•

•

Results

No previous studies have evaluated the breadth &
depth of endocrine curricula at United States (US)
schools & colleges of pharmacy
Most endocrine topics are considered “Tier I” or
“Tier 2” in the ACCP Pharmacotherapy Toolkit,
suggesting they must be sufficiently covered to
prepare students to provide care upon graduation
and licensure.1
As PharmD curricula expand and content is
removed or downsized, it is important to identify
what content to retain/prioritize

Objective
• To determine the breadth and depth of endocrine
instruction and assessment within pre-APPE
coursework in the clinical sciences across US
PharmD programs

Methods
•
•

•
•

•

•

Cross-sectional survey-based study
Seventeen-question Qualtrics® survey distributed
electronically to one targeted individual at each US
PharmD program determined as most likely to be
teaching with the endocrine curriculum
Items included evaluation of specific endocrine
content, contact hours, assessment strategies, and
Entrustable Professional Activities (EPAs)
Inclusion Criteria: US schools & colleges of
pharmacy that are accredited by or in candidate
status with the Accreditation Council for Pharmacy
Education
Statistical Methods: Data were summarized using
descriptive statistics. Chi-square tests were used to
assess the association between categorical
variables (Fisher’s exact tests used instead when
expected frequencies < 5). Mann-Whitney-U tests
and Kruskal-Wallis tests were used for evaluating
ordinal variables. A priori significance level was set
at 0.05.
IRB Approval: Exempt status approval by
Presbyterian College IRB
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Fifty-eight of 142 (40.8%) programs participated.
Coverage of topics and contact hours varied
considerably (Panels 1-3)
For 10 topics, the perception of topic importance
differed between programs that cover and those that
do not cover the topic (p<0.05) (Panel 4)
The most common assessment strategies were
case studies, multiple choice questions, SOAP note
writing and skills demonstration, though other
methods are also used (Panel 5)
Inclusion of diabetes-related EPAs was generally
consistent across programs (Panel 6)
Lack of curricular time was the most commonly cited
barrier to covering additional endocrine topics,
followed by faculty perceptions of importance and
availability of faculty expertise. (Panel 7)
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Discussion & Conclusions
•

Results
•
•

Panel 3

Panel 2

•
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Panel 7

•

There is inconsistency in endocrine curricular across US PharmD programs, including topics covered,
contact hours, assessment strategies, and perception of topic importance
There is a disparity between what is covered in didactic coursework (most topics covered in >70% of
programs) and what is reinforced through laboratory coursework (only type 2 diabetes present in
required labs for >50% of programs)
There is wide variation in the number of contact hours dedicated to endocrine coursework in clinical
sciences
In general, “Tier 1” topics in the ACCP Pharmacotherapy Toolkit1 were consistently present in required
coursework, “Tier 3” topics were generally absent, and the most variation was observed for topics falling
within “Tier 2”
Several discrepancies were noted between coverage & faculty perception of importance of various
topics, such as:
• Gender affirming hormone therapy: 53% of programs responded not covering anywhere in the
curriculum, although there was a wide range in responses regarding perceived importance
• Prediabetes: 100% of programs responded it’s at least moderately important, yet 7% of programs
not currently covering in required didactic coursework
Despite the variety of approaches, respondents consistently noted their methods were appropriately
educating student pharmacists to develop diabetes-related EPAs.

